APA (7th ed.) Citation

Stewart Coats, A. J., Srinivasan, V., Surendran, J., Chiramana, H., Vangipuram, S. R. K. G., Bhatt, N. N., . . . Anker, S. D. (2011). The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer: Study design. Springer.

Chicago Style (17th ed.) Citation

Stewart Coats, Andrew J., et al. The ACT-ONE Trial, a Multicentre, Randomised, Double-blind, Placebo-controlled, Dose-finding Study of the Anabolic/catabolic Transforming Agent, MT-102 in Subjects with Cachexia Related to Stage III and IV Non-small Cell Lung Cancer and Colorectal Cancer: Study Design. Springer, 2011.

MLA (8th ed.) Citation

Stewart Coats, Andrew J., et al. The ACT-ONE Trial, a Multicentre, Randomised, Double-blind, Placebo-controlled, Dose-finding Study of the Anabolic/catabolic Transforming Agent, MT-102 in Subjects with Cachexia Related to Stage III and IV Non-small Cell Lung Cancer and Colorectal Cancer: Study Design. Springer, 2011.